Marshman Fund Trust II 3
3 · Harmony Biosciences Holdings, Inc. · Filed Aug 18, 2020
Insider Transaction Report
Form 3
Marshman Fund Trust II
10% Owner
Holdings
- 6,931,763
Common Stock
Series A Preferred Stock
[F1]→ Common Stock (3,043,213 underlying)
Footnotes (1)
- [F1]The Series A Preferred Stock is convertible into Common Stock on a 8.215-for-1 basis into the number of shares of Common Stock as shown in Column 3 at the holder's election and automatically upon the closing of the Issuer's initial public offering without payment or further consideration. These shares have no expiration date.
Signature
Marshaman Fund Trust II, By: /s/ Stephanie Wisdo, as Attorney-in-fact for Charles Harris, Authorized Signatory|2020-08-18